Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2024-02-21
2025-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Relationship Between Kinesiophobia, Physical Activity and Disability Level and Pain Management in Patients With CLBP
NCT06125496
Answerability and Minimal Clinical Significance of the Pain Questionnaires
NCT06271447
Reliability, Validity Of The Turkish Version Of The Back Performance Scale
NCT03298490
Turkish Validity and Reliability of the UW Concerns About Pain Scale
NCT05201716
Reliabılıty,Validity Of The Turkish Version Of The Back Pain Function Scale
NCT03175510
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
survey
Demographic and clinical information of the participants will be recorded using a standardized form. The cognitive status of the patient will be evaluated according to the answers to the questions asked to the patient during the questioning of demographic data and reading and signing the consent form. The participants will be asked to complete a series of questionnaires to assess pain intensity and characteristics, pain-related functional disability, and pain-related fear-avoidance behavior. To record the presence and severity of pain behaviors exhibited during physical performance tests, patients will be asked to complete 5 functional tests (repetitive trunk flexion, repetitive sit-to-stand, timed get-up-and-go test, reach with load, 50-step walk test) and observers will simultaneously complete the Pain Behavior Scale. Each participant will be asked to attend two testing sessions separated by one week and occurring before the start of treatment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being between the ages of 18-55
* Adequate cognitive functions (reading, writing, recall, orientation, language)
Exclusion Criteria
* Presence of spinal stenosis
* Presence of signs of radiculopathy (presence of neural symptoms such as pain radiating to the lower extremities, weakness, numbness and tingling sensation)
* Presence of fracture or surgical history in the relevant area
* Presence of rheumatic disease history
* Presence of pregnancy
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Acibadem University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elif E Safran, asst. prof.
Role: PRINCIPAL_INVESTIGATOR
Acibadem Healthcare Group
Irmak Çavuşoğlu, asst. prof.
Role: STUDY_CHAIR
Acibadem Healthcare Group
Nuray Alaca, assoc. prof.
Role: STUDY_DIRECTOR
Acibadem Healthcare Group
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Acıbadem Health Group
Istanbul, None Selected, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-15/518
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.